Search Count: 12
All
Selected
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.71 Å Release Date: 2026-04-22 Classification: VIRAL PROTEIN Ligands: A1DAK |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.87 Å Release Date: 2026-04-22 Classification: VIRAL PROTEIN Ligands: GOL, A1DA8, NA |
 |
Crystal Structure Of Htlv-1 Protease Bound To Darunavir At 2.1 Angstroms With Truncated Flaps
Organism: Human t-cell leukemia virus type i
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2026-01-21 Classification: VIRAL PROTEIN/INHIBITOR Ligands: PG4, 017, DMS, PO4 |
 |
Crystal Structure Of Htlv-1 Protease Bound To Umass6 At 2.7 Angstroms With Truncated Flaps
Organism: Human t-cell leukemia virus type i
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2026-01-21 Classification: VIRAL PROTEIN/INHIBITOR Ligands: PG4, A60 |
 |
Crystal Structure Of Sars-Cov-2 Mpro S10A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro S10C In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: DMS, EDO, V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro S113A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.97 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro S113C In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.28 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro L115A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.21 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro L115M In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.19 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro S147A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.13 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro S147N In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |